1INSERM, CMME, Paris.
Evaluating changes in negative symptoms during clinical trials presents challenges. Key limitations include selecting specific patient groups and controlling factors like depression that can mimic negative symptoms.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: